1. bookVolumen 59 (2009): Heft 3 (September 2009)
Zeitschriftendaten
License
Format
Zeitschrift
eISSN
1846-9558
ISSN
1330-0075
Erstveröffentlichung
28 Feb 2007
Erscheinungsweise
4 Hefte pro Jahr
Sprachen
Englisch
Uneingeschränkter Zugang

Compressed matrix dual-component vaginal drug delivery system containing metoclopramide hydrochloride

Online veröffentlicht: 09 Oct 2009
Volumen & Heft: Volumen 59 (2009) - Heft 3 (September 2009)
Seitenbereich: 273 - 288
Zeitschriftendaten
License
Format
Zeitschrift
eISSN
1846-9558
ISSN
1330-0075
Erstveröffentlichung
28 Feb 2007
Erscheinungsweise
4 Hefte pro Jahr
Sprachen
Englisch

K. Vermani and S. Garg, The scope and potential of vaginal drug delivery, PSTT, 3 (2000) 359-364; DOI: S1461-5347(00)00296-0.10.1016/S1461-5347(00)00296-0Search in Google Scholar

P. Colombo, U. Conte and A. Gazzaniga, Drug release modulation by physical restrictions of matrix swelling, Int. J. Pharm. 63 (1990) 43-48; DOI: 10.1016/0378-5173(90)90099-P.10.1016/0378-5173(90)90099-PSearch in Google Scholar

Y. Qiu, N. Chidambaram and K. Flood, Design and evaluation of layered diffusional matrices for zero-order sustained release, J. Control. Rel. 51 (1998) 123-130; DOI: PII S0168-3659(97)00119-3.10.1016/S0168-3659(97)00119-3Search in Google Scholar

N. Chidambaram, W. Porter, K. Flood and Y. Qui, Formulation and characterization of new layered diffusional matrices for zero-order sustained release, J. Control. Rel. 52 (1998) 149-158; DOI: 10.1016/S0168-3659(97)00207-1.10.1016/S0168-3659(97)00207-1Search in Google Scholar

U. Conte and L. Maggi, A flexible technology for the linear, pulsative and delayed release drugs, allowing for easy accommodation of difficult in vitro targets, J. Control. Rel. 64 (2000) 263-268; DOI: 10.1016/S0168-3659(99)00147-9.10.1016/S0168-3659(99)00147-9Search in Google Scholar

N. M. Zakia, G. A. Awada, N. D. Mortadaa, S. Seham and A. E. Hady, Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties, Eur. J. Pharm. Sci. 3 (2007) 296-307; DOI: 10.1016/j.ejps.2007.08.006.10.1016/j.ejps.2007.08.006Search in Google Scholar

S. Lybak, E. Kjellen, P. Nilsson, A. Tomaszewicz, J. Wennerberg and R. W. Pero, Normal tissue reactions in mice after combined treatment with metoclopramide and ionizing radiation, Acta Oncol. 31 (1992) 469-474.10.3109/02841869209088291Search in Google Scholar

J. Wennerberg, E. Kjellen, S. Lybak, R. Rydell and R. Pero, Biochemical modulation of chemotherapy and radiotherapy in head and neck cancer, Anticancer Res. 13 (1993) 2501-2506.Search in Google Scholar

A. Olsson, Y. Sheng, E. Kjellen and R. W. Pero, In vivo tumor measurement of DNA damage, DNA repair and NAD pools as indicators of radiosensitization by metoclopramide, Carcinogenesis 16 (1995) 1029-1035.10.1093/carcin/16.5.1029Search in Google Scholar

R. A. Harrington, C. W. Hamilton, R. N. Brogden, J. A. Linkewich, J. A. Romankiewicz and R. C. Heel, Metoclopramide: an updated review of its pharmacological properties and clinical use, Drugs 25 (1983) 451-494.Search in Google Scholar

D. M. Brahmankar and S. B. Jaiswal, Application of Pharmacokinetic Principles-Biopharmaceutics and Pharmacokinetics, 1st ed., Vallaph Prakashan, Delhi 1998, p. 311.Search in Google Scholar

H. C. Ansel, L. V. Allen and N. G. Popovich, Capsules and Tablets, in Pharmaceutical Dosage Forms and Drug Delivery Systems, 7th ed., Lippincott Williams & Wilkins, Philadelphia 2002, pp. 204-209.Search in Google Scholar

C. N. Patra, A. B. Kumar, H. K. Pandit, S. P. Singh and M. V. Devi, Design and evaluation of sustained release bilayer tablets of propranolol hydrochloride, Acta Pharm. 57 (2007) 479-489; DOI: 10.2478/v10007-007-0038-010.2478/v10007-007-0038-0Search in Google Scholar

United States Pharmacopoeia 28, National Formulary 23, Asian Edition, USP Convention, Rockville (MD) 2005, p. 1277.Search in Google Scholar

Guidance for Industry, SUPAC-MR: Modified Release Solid Oral Dosage Forms. Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls; In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation, U. S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) September 1997, CMC 8, Rockville (MD) 1997, p. 32.Search in Google Scholar

P. Costa, J. Manuel and S. Labao, Modeling and comparison of dissolution profiles, Eur. J. Pharm. Sci. 13 (2001) 123-133; DOI: 10.1016/S0928-0987(01)00095-1.10.1016/S0928-0987(01)00095-1Search in Google Scholar

R. W. Korsmeyer, R. Gurny, E. Docler, P. Buri and N. A. Peppas, Mechanism of solute release from porous hydrophilic polymers, Int. J. Pharm. 15 (1983) 25-35; DOI: 10.1016/0378-5173(83)90064-9.10.1016/0378-5173(83)90064-9Search in Google Scholar

N. A. Peppas, Analysis of Fickian and non Fickian drug release from polymers, Pharm. Acta Helv. 60 (1985) 110-111.Search in Google Scholar

N. Adel, N. Fatma, A. Ismail, N. A. Boraie and L. M. Mortada, Mucoadhesive delivery systems. I. Evaluation of mucoadhesive polymers for buccal tablet formulation, Drug. Dev. Ind. Pharm. 30 (2004) 985-993; DOI: 10.1081/DDC-200037245.10.1081/DDC-200037245Search in Google Scholar

J. Moore and H. Flanner, Mathematical comparison of dissolution profiles, Pharm. Tech. 20 (1996) 64-74.Search in Google Scholar

Empfohlene Artikel von Trend MD

Planen Sie Ihre Fernkonferenz mit Scienceendo